This webinar, which was run on 30 April, provides an overview of some recent patent cases and changes to the relevant patent law regimes that are of particular interest to the life sciences sector. Topics covered include the unitary patent, the unified patents court agreement, Neurim Pharmaceuticals v Comptroller-General of Patents, Actavis v Eli Lilly, Novartis v Generics, Brustle v Greenpeace, the extension of the UK Bolar research exception and some other highlights.
A smattering of recent relevant patent law developments